Flubrotizolam has become known as a highly active benzodiazepine analogue. Introduced for limited purposes, flubrotizolam possesses intense anxiolytic effects. Its structural properties illustrate a high affinity for the GABA receptor, resulting significant CNS modulation. Despite its potential therapeutic applications, flubrotizolam's unregulated